The Role of Cetuximab in the Treatment of Metastatic Colorectal Cancer

被引：0
|
作者：
Holubec, Lubos [1 ]
Liska, Vaclav [2 ]
Matejka, Vit M. [1 ]
Fiala, Ondrej [1 ]
Dreslerova, Jana [1 ]
Mrazkova, Petra [3 ,4 ]
Treska, Vladislav [2 ]
Finek, Jindrich [1 ]
机构：
[1] Charles Univ Prague, Dept Oncol & Radiotherapy, Sch Med, Prague, Czech Republic
[2] Charles Univ Prague, Dept Surg, Sch Med, Prague, Czech Republic
[3] Charles Univ Prague, Dept Radiol, Sch Med, Prague, Czech Republic
[4] Charles Univ Prague, Teaching Hosp Pilsen, Prague, Czech Republic
来源：
ANTICANCER RESEARCH | 2012年 / 32卷 / 09期
关键词：
KRAS; cetuximab; colorectal cancer; liver metastases; review; PLUS IRINOTECAN; 1ST-LINE TREATMENT; COMBINATION CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; LIVER METASTASES; OXALIPLATIN; FLUOROPYRIMIDINE; LEUCOVORIN; RESECTION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeted biological therapy is becoming a standard in personalized medicine for patients with advanced stages of cancer. Treatment with cetuximab, an anti-epidermal growth factor receptor (EGFR) antibody, represents an example of personalized anticancer the for patients with metastatic colorectal cancer and wild (non-mutated) type of the Kirsten rat sarcoma viral oncogene (KRAS). Here the role of cetuximab in treating metastatic colorectal cancer is discussed with a focus on the treatment of hepatic metastases.
引用
收藏
页码：4007 / 4011
页数：5
相关论文
共 50 条
  • [21] Cetuximab for the first-line treatment of metastatic colorectal cancer
    Meads, C.
    Round, J.
    Tubeuf, S.
    Moore, D.
    Pennant, M.
    Baylis, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 8
  • [22] Cetuximab therapy in the treatment of metastatic colorectal cancer: The future frontier?
    Gomez, D.
    De Rosa, A.
    Addison, A.
    Brooks, A.
    Malik, H. Z.
    Cameron, I. C.
    INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (07) : 507 - 513
  • [23] Treatment of Metastatic Colorectal Cancer with Cetuximab: Influence on the Quality of Life
    Unger, K.
    Niehammer, U.
    Hahn, A.
    Goerdt, S.
    Schumann, M.
    Thum, S.
    Schepp, W.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (08): : 733 - 739
  • [24] Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer
    Feng Wen
    Qiu Li
    World Journal of Gastroenterology, 2016, (23) : 5332 - 5341
  • [25] Cetuximab in Combination with Chemotherapy in the Initial Treatment of Metastatic Colorectal Cancer
    Ghadimi, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (12) : 840 - 842
  • [26] COST ANALYSIS OF METASTATIC COLORECTAL CANCER TREATMENT WITH BEVACIZUMAB AND CETUXIMAB
    Maria Vieitez, Jose
    Oyaguez, Itziar
    Angel Casado, Miguel
    ANNALS OF ONCOLOGY, 2011, 22 : v84 - v84
  • [27] Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK
    Barnett, David
    Stevens, Andrew
    Longson, Carole
    LANCET ONCOLOGY, 2006, 7 (10): : 807 - 808
  • [28] Cetuximab for Metastatic Colorectal Cancer.
    Spiro, Howard
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01): : 95 - 95
  • [29] Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani, Francesco
    Cunningham, David
    LANCET ONCOLOGY, 2014, 15 (10): : 1040 - 1041
  • [30] Cetuximab in metastatic colorectal cancer Reply
    Folprecht, Gunnar
    Koehne, Claus-Henning
    LANCET ONCOLOGY, 2010, 11 (04): : 314 - 314
12345